Brainsway (BWAY) Stock: Why It Rose
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $11.99, +4.81% vs the prior close of $11.44.
- Volume 109.00K shares, 1.0x its 50-day average.
- New SEC filings: 6-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Medline (MDLN)
BWAY jumps 4.8% to $11.99. Closed at $11.99, +4.81% vs the prior close of $11.44. Day range $11.86–$12.14, opened at $11.86.
BWAY daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BWAY jumps 4.8% to $11.99
- Closed at $11.99, +4.81% vs the prior close of $11.44. Day range $11.86–$12.14, opened at $11.86.
- Volume was 108.95K shares, 1.0x its 50-day average of 111.77K.
- Price is -12.3% vs its 50-day average ($13.67) and -13.8% vs its 200-day average ($13.91).
- 52-week range $7.14–$17.40; today's close sits at 47% of that range, 31.1% below the 52-week high.
- SEC filings that day: 6-K.
Oct 16, 2026 — BWAY slides 3.2% to $11.44, a 6-month low
- Closed at $11.44, -3.21% vs the prior close of $11.82. Day range $11.36–$11.87, opened at $11.87.
- Volume was 66.29K shares, 0.6x its 50-day average of 112.85K — lighter than usual.
- Price is -16.7% vs its 50-day average ($13.74) and -17.7% vs its 200-day average ($13.89).
- 52-week range $7.14–$17.40; today's close sits at 42% of that range, 34.3% below the 52-week high.
Oct 15, 2026 — BWAY rises 2.7% to $11.82
- Closed at $11.82, +2.69% vs the prior close of $11.51. Day range $11.34–$11.90, opened at $11.51.
- Volume was 109.60K shares, 1.0x its 50-day average of 112.33K.
- Price is -14.5% vs its 50-day average ($13.82) and -14.9% vs its 200-day average ($13.88).
- 52-week range $7.14–$17.40; today's close sits at 46% of that range, 32.1% below the 52-week high.
Oct 14, 2026 — BWAY slides 3.4% to $11.51
- Closed at $11.51, -3.44% vs the prior close of $11.92. Day range $11.47–$11.79, opened at $11.70.
- Volume was 114.70K shares, 1.0x its 50-day average of 112.86K.
- Price is -17.1% vs its 50-day average ($13.89) and -17.0% vs its 200-day average ($13.87).
- 52-week range $7.14–$17.40; today's close sits at 43% of that range, 33.9% below the 52-week high.
Oct 13, 2026 — BWAY jumps 4.0% to $11.92
- Closed at $11.92, +4.01% vs the prior close of $11.46. Day range $11.80–$12.18, opened at $11.86.
- Volume was 150.80K shares, 1.4x its 50-day average of 111.57K.
- Price is -14.7% vs its 50-day average ($13.97) and -14.0% vs its 200-day average ($13.86).
- 52-week range $7.14–$17.40; today's close sits at 47% of that range, 31.5% below the 52-week high.
- SEC filings that day: 6-K.
Oct 12, 2026 — BWAY dips 2.6% to $11.46, a 6-month low
- Closed at $11.46, -2.63% vs the prior close of $11.77. Day range $11.41–$11.63, opened at $11.56.
- Volume was 158.30K shares, 1.4x its 50-day average of 112.00K.
- Price is -18.4% vs its 50-day average ($14.05) and -17.3% vs its 200-day average ($13.85).
- 52-week range $7.14–$17.40; today's close sits at 42% of that range, 34.1% below the 52-week high.
Oct 9, 2026 — BWAY rises 2.6% to $11.77
- Closed at $11.77, +2.62% vs the prior close of $11.47. Day range $11.36–$12.13, opened at $11.36.
- Volume was 104.10K shares, 0.9x its 50-day average of 111.56K.
- Price is -16.7% vs its 50-day average ($14.13) and -15.0% vs its 200-day average ($13.84).
- 52-week range $7.14–$17.40; today's close sits at 45% of that range, 32.4% below the 52-week high.
Oct 8, 2026 — BWAY dips 1.3% to $11.47, a 6-month low, 7 down days in a row
- Closed at $11.47, -1.29% vs the prior close of $11.62. Day range $11.37–$11.61, opened at $11.59.
- Volume was 119.70K shares, 1.1x its 50-day average of 112.55K.
- Price is -19.2% vs its 50-day average ($14.20) and -17.1% vs its 200-day average ($13.83).
- 52-week range $7.14–$17.40; today's close sits at 42% of that range, 34.1% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 — BWAY dips 2.3% to $11.62, a 6-month low, 6 down days in a row
- Closed at $11.62, -2.27% vs the prior close of $11.89. Day range $11.45–$11.77, opened at $11.60.
- Volume was 132.40K shares, 1.2x its 50-day average of 111.87K.
- Price is -18.5% vs its 50-day average ($14.25) and -15.9% vs its 200-day average ($13.82).
- 52-week range $7.14–$17.40; today's close sits at 44% of that range, 33.2% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — BWAY dips 2.8% to $11.89, a 6-month low, 5 down days in a row
- Closed at $11.89, -2.78% vs the prior close of $12.23. Day range $11.74–$12.30, opened at $12.23.
- Volume was 143.60K shares, 1.3x its 50-day average of 113.48K.
- Price is -17.0% vs its 50-day average ($14.33) and -13.8% vs its 200-day average ($13.80).
- 52-week range $7.14–$17.40; today's close sits at 46% of that range, 31.7% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — BWAY dips 2.2% to $12.23, a 6-month low on 2.0x normal volume
- Closed at $12.23, -2.16% vs the prior close of $12.50. Day range $11.93–$12.34, opened at $12.29.
- Volume was 231.20K shares, 2.0x its 50-day average of 114.76K — unusually heavy trading.
- Price is -15.1% vs its 50-day average ($14.41) and -11.2% vs its 200-day average ($13.78).
- 52-week range $7.14–$17.40; today's close sits at 50% of that range, 29.7% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — BWAY dips 0.8% to $12.50, a 3-month low, 3 down days in a row
- Closed at $12.50, -0.79% vs the prior close of $12.60. Day range $12.41–$12.96, opened at $12.75.
- Volume was 50.80K shares, 0.4x its 50-day average of 117.77K — lighter than usual.
- Price is -13.7% vs its 50-day average ($14.48) and -9.2% vs its 200-day average ($13.76).
- 52-week range $7.14–$17.40; today's close sits at 52% of that range, 28.2% below the 52-week high.
- That makes 3 straight losses.
BWAY bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- Price is -12.3% vs its 50-day average — short-term trend is down.
- Price is -13.8% vs its 200-day average — below the long-term trend line.
- Insider selling outweighs buying: 25 sales vs 0 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BWAY latest news & SEC filings
Every SEC filing by or about BWAY in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moiseyev Gilad sold 5,000 shares on Jun 15, 2026
- Moiseyev Gilad sold 5,000 shares on Jun 15, 2026
- Moiseyev Gilad sold 5,000 shares on Jun 15, 2026
- Moiseyev Gilad sold 5,000 shares on Jun 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade BWAY
- How much it moves: over the last 20 sessions the average daily move was 2.29% (largest 4.8%).
- Liquidity: about 119.66K shares (≈$1.43M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $11.99 vs a range of $7.14–$17.40 (47% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 2:1 on Mar 4, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Gilad Moiseyev sold 5,000 shares on Jun 15, 2026.
- Latest filings: 6-K Oct 19, 2026; 6-K Oct 13, 2026; 6-K Sep 29, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
BWAY market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 11.86 | 12.15 | 11.84 | 11.99 | 109.00K |
| Oct 16, 2026 | 11.87 | 11.87 | 11.36 | 11.44 | 66.30K |
| Oct 15, 2026 | 11.51 | 11.90 | 11.34 | 11.82 | 109.60K |
| Oct 14, 2026 | 11.70 | 11.79 | 11.47 | 11.51 | 114.70K |
| Oct 13, 2026 | 11.86 | 12.18 | 11.80 | 11.92 | 150.80K |
| Oct 12, 2026 | 11.56 | 11.63 | 11.41 | 11.46 | 158.30K |
| Oct 9, 2026 | 11.36 | 12.13 | 11.36 | 11.77 | 104.10K |
| Oct 8, 2026 | 11.59 | 11.61 | 11.37 | 11.47 | 119.70K |
| Oct 7, 2026 | 11.60 | 11.77 | 11.45 | 11.62 | 132.40K |
| Oct 6, 2026 | 12.23 | 12.30 | 11.74 | 11.89 | 143.60K |
| Oct 5, 2026 | 12.29 | 12.34 | 11.93 | 12.23 | 231.20K |
| Oct 2, 2026 | 12.75 | 12.96 | 12.41 | 12.50 | 50.80K |
| Oct 1, 2026 | 12.91 | 12.99 | 12.50 | 12.60 | 137.90K |
| Sep 30, 2026 | 13.56 | 13.84 | 13.17 | 13.20 | 70.70K |
| Sep 29, 2026 | 13.36 | 13.99 | 13.16 | 13.48 | 113.40K |
| Sep 28, 2026 | 13.10 | 13.44 | 12.99 | 13.25 | 179.10K |
| Sep 25, 2026 | 13.21 | 14.38 | 13.07 | 13.31 | 54.50K |
| Sep 24, 2026 | 13.25 | 13.30 | 13.06 | 13.21 | 65.80K |
| Sep 23, 2026 | 13.83 | 14.11 | 13.44 | 13.45 | 90.40K |
| Sep 22, 2026 | 13.14 | 13.72 | 13.02 | 13.63 | 190.90K |
About Brainsway
Brainsway (BWAY) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in Jerusalem, Israel. State of incorporation: Israel. Fiscal year ends —. SEC CIK 1505065.
BWAY board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Amiram Boehm | Director | Mar 18, 2026 |
| Avner Lushi | Director | Mar 18, 2026 |
| Rayten Michal Ety Mitrany | Director | May 26, 2026 |
| Karen Sarid | Director | Mar 18, 2026 |
| Jonathan K Shulkin | Director | Mar 18, 2026 |
| David Zacut | Director | Mar 18, 2026 |
| Abraham Zangen | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Colleen Hanlon | VP of Medical Affairs | Mar 18, 2026 |
| Hadar Levy | Chief Executive Officer | Mar 18, 2026 |
| Ido Marom | Chief Financial Officer | Mar 18, 2026 |
| Gilad Moiseyev | Chief Technology Officer | Jun 22, 2026 |
| Yiftach Roth | Chief Scientist | Jun 3, 2026 |
| Naomi Rozenfeld | Chief Marketing Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 15, 2026 | Gilad Moiseyev | Sale | 5,000 | — |
| Jun 15, 2026 | Gilad Moiseyev | Sale | 5,000 | — |
| Jun 15, 2026 | Gilad Moiseyev | Sale | 5,000 | — |
| Jun 15, 2026 | Gilad Moiseyev | Sale | 5,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 1,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 1,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 1,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 2, 2026 | Yiftach Roth | Sale | 1,000 | — |
| Jun 1, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 1, 2026 | Yiftach Roth | Sale | 2,000 | — |
| Jun 1, 2026 | Yiftach Roth | Sale | 2,000 | — |
BWAY financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
BWAY earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Tesla (TSLA)Space Exploration Technologies (SPCX)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BWAY
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.